Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines
Journal of Thyroid Research · 2012
DOI: 10.1155/2012/512401 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Thyroid Research, 2012. Verfasst von Hala Ahmadieh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, 3 Dag Hammarskjold Plaza, New York, NY 1001…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Thyroid cancer is among the most common endocrine malignancies. Genetic and environmental factors play an important role in the pathogenesis of differentiated thyroid cancer. Both have good prognosis but with frequent recurrences. Cancer staging is an essential prognostic part of cancer management. There are multiple controversies in the management and followup of differentiated thyroid cancer. Debate still exists with regard to the optimal surgical approach but trends toward a more conservative approach, such as lobectomy, are being more favored, especially in papillary thyroid cancer, of tumor sizes less than 4 cm, in the absence of other high-risk suggestive features. Survival of patients with well-differentiated thyroid cancer was adversely affected by lymph node metastases. Prophylactic central LN dissection did improve accuracy in staging and decrease postop TG level, but it had no effect on small-sized tumors. Conservative approach was more applied with regard to the need and dose of radioiodine given postoperatively. There have been several advancements in the management of radioiodine resistant advanced differentiated thyroid cancers. Appropriate followup is required based on risk stratification of patients postoperatively. Many studies are still ongoing in order to reach the optimal management and followup of differentiated thyroid cancer.
Autor:innen und Institutionen
- Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, 3 Dag Hammarskjold Plaza, New York, NY 10017, USA.
Zitieren
APA
Ahmadieh, H., & Azar, S. T. (2012). Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines. Journal of Thyroid Research. https://doi.org/10.1155/2012/512401
Vancouver
Ahmadieh H, Azar ST. Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines. Journal of Thyroid Research. 2012. doi:10.1155/2012/512401
BibTeX
@article{Ahmadieh2012,
author = {Ahmadieh, Hala and Azar, Sami T},
title = {Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines},
journal = {Journal of Thyroid Research},
year = {2012},
doi = {10.1155/2012/512401}
}
EUVIMED